Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Neurobiol Aging. 2015 Mar 14;36(6):2010–2017. doi: 10.1016/j.neurobiolaging.2015.03.007

Table 1.

Subjects' characteristics.

CN n = 60 DLB n = 30 AD n = 30 p-value*
Females (%) 10 (17) 5 (17) 5 (17) 1.0
Age (y) 68.5 (63, 76) 69 (63, 76) 72.5 (64, 79) 0.48
Education (y) 15.5 (12.5, 18) 15 (12, 18) 16 (12, 18) 0.69
APOE ε4 carriers (%) 11 (18) 13 (43) 23 (77) <0.001
CDR sum of boxes 0.0 (0.0, 0.0) 5.75 (4.0, 7.0) 4.75 (2.5, 7.0) <0.001
MMSE 29 (28, 29) 20.5 (15, 24) 21 (14, 23) <0.001
DRS - 125.5 (114, 131) 111 (85, 127) 0.03
PiB SUVR 1.31 (1.27, 1.37) 1.43 (1.30, 1.88) 2.35 (2.17, 2.52) <0.001
VH present (%) - 23 (77) 2 (8) <0.001
Fluctuations present (%) - 27 (90) 2 (8) <0.001
Motor UPDRS - 12 (7, 14) 0 (0, 2) <0.001
RBD present (%) - 28 (93) 4 (15) <0.001
Dementia duration (y) - 5.04 (3.75, 7.17) 5.21 (3.50, 7.00) 0.88
VH duration (y) - 1.91 (0.75, 3.59) - -
Fluctuations duration (y) - 2.25 (1.49, 3.67) - -
Parkinsonism duration (y) - 3.50 (1.17, 5.75) - -
RBD duration (y) - 9.21 (4.16, 14.08) - -

Medians (IQR) are listed for the continuous and the proportions (%) are for the categorical variables.

*

p-values are from the Wilcoxon rank sum for the continuous variables, and a χ2 test for differences in proportions. VH = visual hallucinations (probable and definite combined together). RBD = probable REM-sleep behavior disorder, SUVR=Standardized uptake value ratio.